Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Merck
US Army
Boehringer Ingelheim
Mallinckrodt
McKesson
Dow
Federal Trade Commission
Accenture
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

MINIPRESS Drug Profile

« Back to Dashboard

When do Minipress patents expire, and when can generic versions of Minipress launch?

Minipress is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in MINIPRESS is prazosin hydrochloride. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
Drug patent expirations by year for MINIPRESS

Pharmacology for MINIPRESS

Medical Subject Heading (MeSH) Categories for MINIPRESS

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMINIPRESS XLprazosin hydrochlorideTABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MINIPRESS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
PfizerMINIPRESSprazosin hydrochlorideCAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKesson
Novartis
Chinese Patent Office
Citi
Daiichi Sankyo
Deloitte
Julphar
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot